Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive–Compulsive Disorder

Selective serotonin reuptake inhibitors (SSRIs) are the only effective pharmacological treatments for obsessive–compulsive disorder (OCD). Nonetheless, their generally limited efficacy, side-effects, and delayed onset of action require improved medications for this highly prevalent disorder. Preclin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Michelle M., Overshiner, Carl, Leander, J. David, Li, Xia, Morrow, Denise, Conway, Richard G., Nelson, David L., Briner, Karin, Witkin, Jeffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438973/
https://www.ncbi.nlm.nih.gov/pubmed/28588509
http://dx.doi.org/10.3389/fpsyt.2017.00089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438973/
https://www.ncbi.nlm.nih.gov/pubmed/28588509
http://dx.doi.org/10.3389/fpsyt.2017.00089

Ejemplares similares